Programme at a glance

Programme at a glance, Paris

Thursday, 4 April 2019

00.01 - 23.59

WCO-IOF-ESCEO

14.30 - 17.00

Auditorium A

Actualités et controverses sur l’arthrose et l’ostéoporose

‣ Symposium conjointement organisé par la Société Française de Rhumatologie (SFR), le Groupe de Recherche et d’Informations sur les Ostéoporoses (GRIO), l’International Osteoporosis Foundation (IOF) et l’European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Chairpersons: ‣ Leith Zakraoui, ‣ Bernard Cortet, ‣ Thierry Thomas

‣ 14h30 : Produits laitiers fermentés et santé osseuse Emmanuel Biver

‣ 14h55 : L’arthrose, une histoire d’alimentation ? Jérémie Sellam

‣ 15h20 : L’arthrose, une maladie inflammatoire ? Florent Eymard

‣ 15h45 : Vitamine D, arthrose et ostéoporose Etienne Cavalier

‣ 16h10 : L’arthrose rachidienne existe-t-elle ? François Rannou

‣ 16h35 : La place de la vertébroplastie, les données sont-elles solides ? Bernard Cortet

‣ 17h00 : Conclusion Thierry Thomas

Symposium organisé en langue française.

17.45 - 20.00

Auditorium A

WCO-IOF-ESCEO - OPENING CEREMONY

Chairpersons: ‣ John A. Kanis, ‣ Jean‑Yves Reginster

17.45

Auditorium A

Best clinical papers published in 2018

‣ René Rizzoli

18.30

Auditorium A

Beyond nutrients: health effects of the dairy matrix

‣ Arne Astrup

19.00

Auditorium A

2018 update of the European guidelines for the diagnosis and management of osteoporosis (ESCEO-IOF)

‣ René Rizzoli

19.15

Auditorium A

Plenary Lecture: Disease in Art Painting

‣ Davide Lazzeri

19.45

Auditorium A

Opening of the meeting

‣ Cyrus Cooper (IOF President, ESCEO Vice‑President)

19.50

Auditorium A

Presentation of the 2019 ESCEO Medal of Excellence

‣ Jean‑Yves Reginster

19.50

Auditorium A

Presentation of the IOF Olof Johnell Science Award

‣ Cyrus Cooper

20.00 - 21.00

INDUSTRY-SPONSORED WELCOME COCKTAIL

^*See details on the Sponsored Satellite Symposia page

Friday, 5 April 2019

00.01 - 23.59

WCO-IOF-ESCEO

08.00 - 09.00

SYMPOSIA

Meeting Room 342A

Patients' preferences for anti-osteoarthritis treatment: A cross-European Discrete Choice Experiment: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Chairpersons: ‣ Mickaël Hiligsmann, ‣ Elaine M. Dennison

‣ 08:00: Welcome and introduction Mickaël Hiligsmann

‣ 08:05: Identification prioritization of important attributes of OA treatment Elaine M. Dennison

‣ 08:20: Results from the cross-European discrete choice experiment Mickaël Hiligsmann

‣ 08:35: Discussion Elaine M. Dennison

‣ 08:55: Conclusion Mickaël Hiligsmann

Meeting Room 351

Osteosarcopenic obesity: enough evidence for a distinct entity: outcomes of an ESCEO experts consensus meeting organized under the auspices of the World Health Organization Collaborating Center for Public Health Aspects of Musculo-skeletal Health and Ageing

Chairpersons: ‣ Islene Araujo de Carvalho, ‣ Roger A. Fielding

‣ 08:00: Introduction Stefania Maggi

‣ 08:05: Osteosarcopenic obesity: Facts and evidence supporting a distinct entity Jürgen Bauer

‣ 08:20: Osteosarcopenic obesity: Lack of evidence supporting a distinct entity Alfonso Cruz Jentoft

‣ 08:35: Discussion Jürgen Bauer

‣ 08:55: Conclusion Roger A. Fielding

Panel: ‣ Islene Araujo de Carvalho, ‣ Jürgen Bauer, ‣ Olivier Bruyère, ‣ Roland D. Chapurlat, ‣ Cyrus Cooper, ‣ Alfonso Cruz Jentoft, ‣ Elaine M. Dennison, ‣ Roger A. Fielding, ‣ John A. Kanis, ‣ Jean‑Marc Kaufman, ‣ Francesco Landi, ‣ Andrea Laslop, ‣ Médéa Locquet, ‣ Stefania Maggi, ‣ Eugene McCloskey, ‣ Simone Perna, ‣ Jean‑Yves Reginster, ‣ René Rizzoli, ‣ Yves Rolland, ‣ Pawel Szulc

08.00 - 09.00

NON-SPONSORED SYMPOSIA

Meeting Room 352A

Real World Evidence in Metabolic Bone Disease

Chairperson: ‣ Daniel Prieto‑Alhambra

‣ Real world data for assessing the use, risks, and benefits of anti-osteoporosis therapies in actual practice conditions Daniel Prieto‑Alhambra

‣ Routinely collected data for the study of the epidemiology of fractures, and for characterising imminent fracture risk Bo Abrahamsen

‣ Health economics using real world data: an introduction Rafael Pinedo‑Villanueva

‣ Real world data for the study of orthopaedics and hip fracture care Alma Pedersen

Meeting Room 341

What’s new in tendinopathies?

Chairperson: ‣ Jean‑François Kaux

‣ Introduction Olivier Bruyère

‣ Tendon physiopathology and imagery... What’s new ? Stijn Bogaerts

‣ Rehabilitation: eccentric or not eccentric? Which physiotherapy? Jean‑Louis Croisier

‣ Which efficacy for the new treatments ? Jean‑François Kaux

Meeting Room 353

Emerging Biomarkers in Vitamin D Metabolism

Chairperson: ‣ Shaun Sabico

‣ Biomarker Discovery Nasser Al‑Daghri

‣ Vitamin D Biomarker Discovery Majed Alokail

‣ Validation Yousef Al‑Saleh

Meeting Room 343

Sarcopenia in older people: actual perspectives

Chairpersons: ‣ Nicola Veronese, ‣ Charlotte Beaudart

‣ The radiological evaluation of muscle mass in older people Giuseppe Guglielmi

‣ Physical performance in older people: actual evidence Olivier Bruyère

‣ The diagnosis of sarcopenia in older people: between research and clinical practice Nicola Veronese

Meeting Room 342B

Female Bone Health: a gynecological approach through routine assistance

Chairperson: ‣ Adriana Orcesi Pedro

‣ Opening: Women´s Hospital - CAISM - University of Campinas message for bone health Adriana Orcesi Pedro

‣ Bone mass and fracture risk during pregnancy and lactation Anna V. Gueldini de Moraes, Fernanda Garanhani de Castro Surita

‣ Update on management of osteoporosis in young women - special clinical situations Adriana Orcesi Pedro, Gabriela Pravatta Rezende

‣ Evaluation and management of osteopenia and osteoporosis in breast cancer survivors Adriana Orcesi Pedro, Cesar Cabello dos Santos

‣ Question & Answers with audience

08.00 - 09.00

Auditorium A

INDUSTRY BREAKFAST SYMPOSIUM

^*See details on the Sponsored Satellite Symposia page

09.00 - 10.30

Auditorium A

SCIENTIFIC SESSION I

Chairpersons: ‣ Jean‑Yves Reginster, ‣ John A. Kanis

09.00

Auditorium A

Plenary Lecture 1

‣ When and why use a bone forming agent?

‣ Eugene McCloskey

09.30

Auditorium A

Oral communication selected from abstracts

09.30

Auditorium A

OC1

‣ HORMONE THERAPY REDUCES THE RISK OF FRACTURE IN FALLERS AND IN NON-FALLERS: RESULTS FROM THE WOMEN’S HEALTH INITIATIVE HORMONE THERAPY TRIALS

Presenting author: ‣ M. Lorentzon

Authors: ‣ H. Johansson, ‣ N. C. Harvey, ‣ E. Liu, ‣ J. Crandall, ‣ E. V. McCloskey, ‣ J. A. Kanis

09.40

Auditorium A

OC2

‣ ROMOSOZUMAB EFFICACY ON FRACTURE OUTCOMES IS GREATER IN PATIENTS AT HIGH BASELINE FRACTURE RISK: A POST HOC ANALYSIS OF THE FRAME STUDY

Presenting author: ‣ E. V. McCloskey

Authors: ‣ M. Lorentzon, ‣ H. Johansson, ‣ N. C. Harvey, ‣ J. A. Kanis

09.50

Auditorium A

OC3

‣ ROMOSOZUMAB ENHANCES 3D VERTEBRAL STRUCTURE IN WOMEN WITH LOW BONE DENSITY: MAPPING BONE GAINS AT ONE YEAR COMPARED WITH TERIPARATIDE OR PLACEBO

Presenting author: ‣ K. E. S. Poole

Authors: ‣ G. M. Treece, ‣ R. A. Pearson, ‣ A. H. Gee, ‣ M. A. Bolognese, ‣ J. P. Brown, ‣ S. Goemaere, ‣ A. Grauer, ‣ D. A. Hanley, ‣ C. Mautalen, ‣ C. Recknor, ‣ Y. C. Yang, ‣ C. Libanati, ‣ T. Whitmarsh

10.00

Auditorium A

OC4

‣ EFFECT OF ABALOPARATIDE ON BONE MINERAL DENSITY AND FRACTURE INCIDENCE IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AND OSTEOARTHRITIS

Presenting author: ‣ N. E. Lane

Authors: ‣ B. Mitlak, ‣ R. Weiss, ‣ Y. Wang, ‣ G. J. Valenzuela, ‣ J. P. Bilezikian

10.10

Auditorium A

OC5

‣ BUROSUMAB IMPROVES THE BIOCHEMICAL, SKELETAL, AND CLINICAL SYMPTOMS OF TUMOR-INDUCED OSTEOMALACIA (TIO) SYNDROME

Presenting author: ‣ S. Jan de Beur

Authors: ‣ P. Miller, ‣ T. Weber, ‣ M. Peacock, ‣ K. Insogna, ‣ R. Kumar, ‣ D. Luca, ‣ T. Cimms, ‣ K. Lampl, ‣ J. San Martin, ‣ T. Carpenter

10.20

Auditorium A

Presentation of the ESCEO-AgNovos Healthcare Young Investigator Awards

‣ Jean‑Yves Reginster

10.30 - 12.10

Auditorium A

SCIENTIFIC SESSION II

Chairpersons: ‣ René Rizzoli, ‣ Cyrus Cooper

10.30

Auditorium A

Presentation of the ESCEO-IOF Herbert Fleisch Medal

‣ René Rizzoli

10.40

Auditorium A

Plenary Lecture 2

‣ Bone fragility and its treatment in chronic renal failure

‣ Peter R. Ebeling

11.10

Auditorium A

Presentation of the IOF President's Award

‣ Cyrus Cooper

11.20

Auditorium A

Oral communication selected from abstracts

11.20

Auditorium A

OC6

‣ IMMINENT (1- AND 2-YEAR) FRACTURE RISK FOLLOWING A FIRST (SENTINEL) FRACTURE: A MULTINATIONAL EUROPEAN COHORT STUDY INCLUDING OVER 700,000 PARTICIPANTS FROM DENMARK, SPAIN, AND THE UK

Presenting author: ‣ D. Prieto‑Alhambra

Authors: ‣ S. Khalid, ‣ M. Thomsen Ernst, ‣ M. K. Javaid, ‣ C. Libanati, ‣ C. Cooper, ‣ A. Delmestri, ‣ D. Martinez‑Laguna, ‣ E. Toth, ‣ B. Abrahamsen

11.30

Auditorium A

OC7

‣ ADJUSTING FRAX FOR IMMINENT RISK

Presenting author: ‣ H. Johansson

Authors: ‣ K. Siggeirsdottir, ‣ N. C. Harvey, ‣ E. V. McCloskey, ‣ V. Gudnason, ‣ G. Sigurdsson, ‣ M. Lorentzon, ‣ E. Liu, ‣ J. A. Kanis

11.40

Auditorium A

OC8

‣ AGE AT HIP FRACTURE: TIME TRENDS OVER TWO DECADES IN A NATIONAL HOSPITAL DISCHARGE REGISTER

Presenting author: ‣ B. Abrahamsen

Authors: ‣ H. V. B. Laursen, ‣ M. K. Skjødt, ‣ M. H. Jensen, ‣ P. Vestergaard

11.50

Auditorium A

OC9

‣ T-SCORE AS AN INDICATOR OF FRACTURE RISK ON THERAPY: EVIDENCE FROM ROMOSOZUMAB VS. ALENDRONATE TREATMENT IN THE ACTIVE-CONTROLLED FRACTURE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS AT HIGH RISK TRIAL

Presenting author: ‣ S. Ferrari

Authors: ‣ F. Cosman, ‣ E. M. Lewiecki, ‣ P. R. Ebeling, ‣ E. Hesse, ‣ N. Napoli, ‣ D. B. Crittenden, ‣ M. Rojeski, ‣ W. Yang, ‣ C. Libanati

12.00

Auditorium A

OC10

‣ FRACTURE INCIDENCE AFTER DENOSUMAB DISCONTINUATION: REAL-WORLD DATA FROM A LARGE HEALTHCARE PROVIDER

Presenting author: ‣ L. Tripto‑Shkolnik

Authors: ‣ N. Fund, ‣ V. Rouach, ‣ G. Chodick, ‣ V. Shalev, ‣ I. Goldshtein

12.15 - 13.45

Auditorium A

INDUSTRY SATELLITE LUNCH SYMPOSIUM

^*See details on the Sponsored Satellite Symposia page

12.15 - 13.45

Auditorium B

INDUSTRY SATELLITE LUNCH SYMPOSIUM

^*See details on the Sponsored Satellite Symposia page

13.45 - 14.00

Podium

IOF Calcium Academy Awards ceremony

‣ Bess Dawson‑Hughes

14.00 - 15.00

MEET-THE-EXPERT SESSIONS

Meeting Room 341

How to assess frailty in daily practice ?

‣ Evelien Gielen

Meeting Room 353

Pre- and postnatal influences on bone and muscle health in children

‣ Nicholas Harvey

Meeting Room 343

Strengths of recommendations for GIOP management

‣ Jonathan Adachi

Meeting Room 352A

Local therapies in osteoarthritis management

‣ François Rannou

Meeting Room 342B

New algorithm for the management of bone fragility in diabetes

‣ Serge Ferrari

14.00 - 15.00

Poster Area

Poster Viewing Session I

14.00 - 15.10

Podium

Oral presentation of selected posters

Chairperson: ‣ Tara Brennan‑Speranza

14.00

Podium

P893

‣ IDENTIFICATION OF PATIENTS AT HIGH RISK FOR OSTEOPOROTIC FRACTURES THROUGH RADIOFREQUENCY ECHOGRAPHIC MULTI SPECTROMETRY (REMS): RESULTS OF A 5-YEAR FOLLOW-UP STUDY

Presenting author: ‣ C. Caffarelli

Authors: ‣ S. Gonnelli, ‣ G. Bianchi, ‣ M. L. Brandi, ‣ S. Casciaro, ‣ L. Cavalli, ‣ L. Cianferotti, ‣ F. Conversano, ‣ A. Fassio, ‣ G. Girasole, ‣ A. Grimaldi, ‣ F. A. Lombardi, ‣ M. Muratore, ‣ P. Pisani, ‣ L. Quarta, ‣ D. Gatti

14.07

Podium

P927

‣ PATIENT AND SERVICE-LEVEL PREDICTORS OF BONE TREATMENT RECOMMENDATION POST-FRACTURE: RESULTS FROM THE UK NATIONAL FRACTURE LIAISON SERVICE (FLS) DATABASE

Presenting author: ‣ M. K. Javaid

Authors: ‣ S. Hawley, ‣ N. Vasilakis, ‣ B. Wiles, ‣ C. L. Gregson, ‣ N. Gittoes, ‣ G. Clunie, ‣ C. Cockill, ‣ I. Price, ‣ A. Judge, ‣ A. Smith

14.14

Podium

P363

‣ FRAILTY IN OLDER COMMUNITY DWELLING ADULTS: A COMPARATIVE STUDY OF THE UK AND JAPAN

Presenting author: ‣ N. Yoshimura

Authors: ‣ E. M. Dennison, ‣ K. A. Jameson, ‣ S. Tanaka, ‣ T. Iidaka, ‣ C. Cooper

14.21

Podium

P154

‣ EWGSOP 2 VERSUS EWGSOP 1: IMPACT ON THE PREVALENCE OF SARCOPENIA AND ITS OUTCOMES

Presenting author: ‣ M. Locquet

Authors: ‣ C. Beaudart, ‣ J. Petermans, ‣ O. Bruyère

14.28

Podium

P639

‣ DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS IS A NEW RISK FACTOR FOR VERTEBRAL FRACTURE IN OLDER MEN – THE PROSPECTIVE MINOS STUDY

Presenting author: ‣ P. Szulc

Authors: ‣ A. Guiot, ‣ R. D. Chapurlat

14.35

Podium

P837

‣ FOR ALL PRACTITIONERS AND RESEARCHERS TO ASSESS HAND DYSFUNCTION IN HAND OSTEOARTHRITIS (OA): THE QUICK, FRIENDLY AND AVAILABLE FOR FREE FUNCTIONAL INDEX FOR HAND OA WEBSITE FIHOA.NET

Presenting author: ‣ E. Maheu

Author: ‣ R.‑L. Dreiser

14.42

Podium

P586

‣ IMMINENT FRACTURE RISK AMONGST NEW USERS OF ORAL BISPHOSPHONATES IN ACTUAL PRACTICE SETTINGS: A MULTI-NATIONAL EUROPEAN COHORT STUDY FROM DENMARK, SPAIN, AND THE UK

Presenting author: ‣ D. Prieto‑Alhambra

Authors: ‣ S. Khalid, ‣ M. Thomsen Ernst, ‣ M. K. Javaid, ‣ C. Libanati, ‣ C. Cooper, ‣ A. Delmestri, ‣ D. Martinez‑Laguna, ‣ E. Toth, ‣ B. Abrahamsen

14.49

Podium

P701

‣ RISK OF HAND OSTEOARTHRITIS IN NEW USERS OF HORMONE REPLACEMENT THERAPY: A NESTED CASE-CONTROL ANALYSIS

Presenting author: ‣ T. Burkard

Authors: ‣ M. Rauch, ‣ J. Spoendlin, ‣ D. Prieto‑Alhambra, ‣ S. S. Jick, ‣ C. R. Meier

14.56

Podium

P1041

‣ CAN WE AVOID THE LOSS OF BONE MINERAL DENSITY ONE YEAR AFTER DENOSUMAB DISCONTINUATION? THE REOLAUS BONE PROJECT

Presenting author: ‣ B. Aubry‑Rozier

Authors: ‣ G. Liebich, ‣ D. Stoll, ‣ E. Gonzalez‑Rodriguez, ‣ D. Hans, ‣ O. Lamy

15.03

Podium

P698

‣ MAJOR OSTEOPOROTIC FRACTURE RISK FOLLOWING BARIATRIC SURGERY: A SELF-CONTROLLED CASE SERIES INCLUDING 5,492 PEOPLE FROM THE UK CPRD AND LINKED HES DATABASES

Presenting author: ‣ D. E. Robinson

Authors: ‣ I. Douglas, ‣ G. D. Tan, ‣ C. Cooper, ‣ A. Delmestri, ‣ M. K. Javaid, ‣ A. Judge, ‣ V. Y. Strauss, ‣ D. Prieto‑Alhambra

14.00 - 15.00

SYMPOSIA

Meeting Room 342A

Reassessment of the safety of anti-osteoarthritis medications: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Chairpersons: ‣ Olivier Bruyère, ‣ Elaine M. Dennison

‣ 14:00: Welcome and scope of the problem Cyrus Cooper

‣ 14:05: Methodology of the ESCEO Working Group Cyrus Cooper

‣ 14:15: Safety of analgesics, non-steroidal anti-inflammatory drugs and opioids Nicholas R. Fuggle

‣ 14:30: Safety of SYSADOAs, intraarticular Hyaluronic Acid and intraarticular corticosteroids Tim McAlindon

‣ 14:45: Discussion Nigel K. Arden

‣ 14:55: Wrap-up and conclusions Nigel K. Arden

Meeting Room 351

Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: outcomes of an ESCEO-IOF experts consensus meeting organized under the auspices of the WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging

Chairpersons: ‣ Adolfo Diez‑Perez, ‣ Stefania Maggi

‣ 14:00: Welcome and scope of the problem Maria Luisa Brandi

‣ 14:05: Determinants of non-adherence to anti-osteoporosis medications Bernard Vrijens

‣ 14:20: Recommendations to improve adherence to anti-osteoporosis medications Mickaël Hiligsmann

‣ 14:35: Recommendations for additional research needed to improve adherence to anti-osteoporosis medications Bo Abrahamsen

‣ 14:45: Discussion (Leader : Sansin Tuzun)

‣ 15:00: Closure of the meeting Adolfo Diez‑Perez

15.00 - 17.00

Auditorium A

SCIENTIFIC SESSION III

Chairpersons: ‣ Charlotte Beaudart, ‣ Bess Dawson‑Hughes

15.00

Auditorium A

Plenary Lecture 3

‣ Early treatment of osteoarthritis

‣ Nigel K. Arden

15.30

Auditorium A

Oral communication selected from abstracts

15.30

Auditorium A

OC11

‣ CARDIOVASCULAR COMORBIDITIES HAS A DELETERIOUS INFLUENCE ON KNEE OA PROGNOSIS AT 5 YEARS: DATA FROM THE PROSPECTIVE KHOALA COHORT

Presenting author: ‣ C. Roubille

Authors: ‣ J. Joel, ‣ S. Sellam, ‣ A. C. Rat, ‣ F. Guillemin, ‣ C. Roux

15.40

Auditorium A

OC12

‣ PREVALENCE OF SARCOPENIA ACCORDING TO THE REVISED EWGSOP DEFINITION AND ITS ASSOCIATIONS WITH BONE STRUCTURE AND INCIDENT FALLS IN SWEDISH OLDER ADULTS

Presenting author: ‣ D. Scott

Authors: ‣ J. Johansson, ‣ L. B. McMillan, ‣ P. R. Ebeling, ‣ P. Nordstrom, ‣ A. Nordstrom

15.50

Auditorium A

OC13

‣ STRENGTH AND PERFORMANCE-BASED OPERATIONAL MEASURES OF SARCOPENIA: PREVALENCE AND ASSOCIATIONS WITH SOCIAL FACTORS AND PHYSICAL DISABILITY IN 10,461 ADULTS AGED 65 YEARS AND OVER FROM SIX LOWER- AND MIDDLE-INCOME COUNTRIES

Presenting author: ‣ S. L. Brennan‑Olsen

Authors: ‣ S. J. Bowe, ‣ P. Kowal, ‣ J. Gaskin, ‣ N. Naidoo, ‣ J. Snodgrass, ‣ T. Quashie, ‣ S. Agrawal, ‣ G. Eick, ‣ C. D'Este

16.00

Auditorium A

OC14

‣ WHICH MUSCLE PARAMETERS ARE LONGITUDINALLY ASSOCIATED WITH FUTURE KNEE OSTEOARTHRITIS OUTCOMES? FINDINGS FROM THE HERTFORDSHIRE COHORT STUDY

Presenting author: ‣ N. R. Fuggle

Authors: ‣ L. D. Westbury, ‣ K. A. Jameson, ‣ H. E. Syddall, ‣ M. H. Edwards, ‣ K. A. Ward, ‣ E. M. Dennison, ‣ C. Cooper

16.10

Auditorium A

OC15

‣ PATIENT ENGAGEMENT IN CLINICAL GUIDELINES DEVELOPMENT: INPUT FROM >1000 MEMBERS OF THE CANADIAN OSTEOPOROSIS PATIENT NETWORK

Presenting author: ‣ L. Funnell

Authors: ‣ M. Djekic‑Ivankovic, ‣ R. Chepesiuk, ‣ L. Giangregorio, ‣ I. Braganca Rodrigues, ‣ R. Ridout, ‣ S. Feldman, ‣ S. Kim, ‣ H. Mcdonald‑Blumer, ‣ G. Kline, ‣ W. E. Ward, ‣ N. Santesso, ‣ W. D. Leslie, ‣ S. N. Morin

16.20

Auditorium A

OC16

‣ RISK OF MAJOR OSTEOPOROTIC FRACTURE AFTER BARIATRIC SURGERY IN FRANCE: POPULATION BASED, RETROSPECTIVE COHORT STUDY

Presenting author: ‣ J. Paccou

Authors: ‣ N. Martignène, ‣ E. Lespessailles, ‣ G. Babykina, ‣ B. Cortet, ‣ G. Ficheur

16.30

Auditorium A

Plenary Lecture 4

‣ Guidelines for the management of osteoarthritis

‣ Jean‑Yves Reginster

15.00 - 16.45

Meeting Room 351

COMMITTEE OF NATIONAL SOCIETIES SPECIAL PLENARY SESSION

‣ Clinical, social, ethical and economic burden of osteoporosis and fragility fractures

Chairpersons: ‣ Jean‑Yves Reginster, ‣ Famida Jiwa, ‣ Philippe Halbout

15.03

Meeting Room 351

OCs1

‣ DETERMINANTS AND HEALTH CONSEQUENCES OF A RAPID MUSCLE HEALTH DECLINE IN OLDER ADULTS FROM THE SARCOPHAGE STUDY

Presenting author: ‣ M. Locquet

Authors: ‣ C. Beaudart, ‣ J.‑L. Croisier, ‣ J.‑Y. Reginster, ‣ O. Bruyère

15.11

Meeting Room 351

OCs2

‣ THE ASSOCIATION BETWEEN RESTING METABOLIC RATE (RMR) AND SARCOPENIC OBESITY (SO) IN OVERWEIGHT AND OBESE ADULT WOMEN

Presenting author: ‣ K. Mirzaei

Authors: ‣ N. Rasaei, ‣ S. F. Sajjadi, ‣ S. A. Keshavarz

15.19

Meeting Room 351

OCs3

‣ WILL THERE BE A FRACTURE IN THEIR FUTURE? BONE MINERAL DENSITY FINDINGS IN YOUNG SOUTH EAST ASIAN WOMEN WITH ANOREXIA NERVOSA

Presenting author: ‣ M. Chandran

Author: ‣ Y. Hao

15.27

Meeting Room 351

OCs4

‣ THE BENEFITS OF REGULAR WEIGHT BEARING ACTIVITY THROUGHOUT THE LIFE-COURSE: DO MEN AND WOMEN REAP THE SAME REWARDS?

Presenting author: ‣ J. Zhang

Authors: ‣ M. A. Clynes, ‣ K. A. Jameson, ‣ C. Cooper, ‣ E. M. Dennison

15.35

Meeting Room 351

OCs5

‣ ASSOCIATION OF 25-HYDROXY VITAMIN D WITH BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN AN IRANIAN ELDERLY POPULATION: BUSHEHR ELDERLY HEALTH (BEH) PROGRAM

Presenting author: ‣ S. Gharibzadeh

Authors: ‣ N. Fahimfar, ‣ G. Shafiee, ‣ R. Heshmat, ‣ N. Mehrdad, ‣ F. Razi, ‣ P. Khashayar, ‣ A. Raiesei, ‣ I. Nabipour, ‣ B. Larijani, ‣ A. Ostovar

15.45

Meeting Room 351

Presentation of the IOF Committee of National Societies Medal

‣ Jean‑Yves Reginster

15.55

Meeting Room 351

OCs6

‣ SERUM VITAMIN D LEVEL ASSOCIATED WITH COGNITIVE AND PHYSICAL FUNCTIONING OF POSTMENOPAUSAL WOMEN

Presenting author: ‣ A. A. Popov

Authors: ‣ N. V. Izmozherova, ‣ E. A. Safianik, ‣ A. A. Vikhareva, ‣ V. M. Bakhtin, ‣ M. A. Shambatov

16.03

Meeting Room 351

OCs7

‣ POSTPARTUM OSTEOPOROSIS ASSOCIATED WITH VERTEBRAL FRACTURES

Presenting author: ‣ N. Temelkova

Authors: ‣ A. Gerganova, ‣ K. Temelkova, ‣ K. Sirakova, ‣ P. Popivanov

16.11

Meeting Room 351

OCs8

‣ VALIDATION OF THE FRACTURE RISK ASSESSMENT TOOL (FRAX) CALCULATOR IN TAIWAN-TWO COHORTS STUDY

Presenting author: ‣ W.‑C. Hung

Authors: ‣ C. H. Wu, ‣ F. W. Liang, ‣ I. T. Liu, ‣ Y. F. Chang, ‣ L. C. Ou, ‣ C. S. Chang, ‣ T. H. Lu

16.19

Meeting Room 351

OCs9

‣ PREVALENCE OF SARCOPENIA IN INDIAN MEN AND WOMEN VARIES ACCORDING TO THE DEFINITION USED

Presenting author: ‣ A. Zengin

Authors: ‣ B. Kulkarni, ‣ A. V. Khadilkar, ‣ V. Ekbote, ‣ N. Kajale, ‣ N. Tandon, ‣ S. K. Bhargava, ‣ H. P. S. Sachdev, ‣ S. Sinha, ‣ C. H. D. Fall, ‣ P. R. Ebeling

16.27

Meeting Room 351

OCs10

‣ VERTEBRAL PAIN AND PHYSICAL PERFORMANCE INDICES IN POSTMENOPAUSAL WOMEN WITH VERTEBRAL FRACTURES DEPENDING ON BONE MINERAL DENSITY PARAMETERS

Presenting author: ‣ N. Grygorieva

Authors: ‣ V. Povoroznyuk, ‣ O. Rybina

16.35

Meeting Room 351

OCs11

‣ FAMILY HISTORY INFLUENCES FRACTURE RISK BMD- INDEPENDENTLY

Presenting author: ‣ A. I. Gasparik

Authors: ‣ M. L. Cevei, ‣ D. Stoicanescu, ‣ T. Szocs

17.00 - 18.30

Auditorium A

INDUSTRY SATELLITE SYMPOSIUM

^*See details on the Sponsored Satellite Symposia page

17.00 - 18.30

Auditorium B

INDUSTRY SATELLITE SYMPOSIUM

^*See details on the Sponsored Satellite Symposia page

Saturday, 6 April 2019

00.01 - 23.59

WCO-IOF-ESCEO

08.00 - 09.00

NON-SPONSORED SYMPOSIA

Meeting Room 341

Vitamin D: as viewed by the laboratory

Chairperson: ‣ Etienne Cavalier

‣ Vitamin D: Optimal levels Harjit Pal Bhattoa

‣ Vitamin D metabolites: Now and Beyond Etienne Cavalier

Meeting Room 352A

FLS in the UK 2014-2018: implementation, standards, quality improvement and benefits

Chairperson: ‣ Bo Abrahamsen

‣ FLS Implementation: An innovative service support model for secondary fracture prevention in the UK Will Carr

‣ Securing funding for service implementation and improvement - demonstrating the benefits and effectiveness of fracture liaison services Tim Jones

‣ Vertebral Fracture Identification – meeting the challenge of FLS standards Jill Griffin

Meeting Room 353

Non-pharmacological treatment of low back pain

Chairperson: ‣ Alexander Barulin

‣ Cognitive-behavioral therapy in the treatment of chronic back pain Olga Kurushina

‣ Biomechanical aspects for understanding of non-specific low-back pain Alexander Barulin

‣ Kinesiotaping in the correction of myofascial back pain Bogdan Kalinchenko

‣ New approaches to the correction of pain in patients with peripheral paralysis Olga Agarkova

Meeting Room 343

Learning on Common Diseases by Understanding the Rare Disorders: The Case of Bone Fragility

Chairperson: ‣ Maria Luisa Brandi

‣ Taxonomy of Metabolic Bone Diseases Laura Masi

‣ FD-MAS Guidelines Naveen Hamdy

‣ Hypophosphatasia in the adults Christian Roux

‣ Phosphate wasting disorders in the adults Kassim Javaid

Meeting Room 342B

Are current treatment recommendations for Osteoarthritis adapted to old/very old patients ?

Chairpersons: ‣ Emmanuel Maheu, ‣ Odile Levy‑Reynaud

‣ How to manage NSAID in the Elderly in knee, hip or hand osteoarthritis treatment? Christian Cadet

‣ Are guidelines for the management of osteoarthritis adapted to very old patients: how to manage opioids in the Elderly in knee, hip or hand osteoarthritis? Odile Levy‑Reynaud

‣ Exercise and weight loss in the management of knee/hip OA in very old patients: current data and how to prescribe Jean‑Laurent Le Quintrec

‣ Total joint replacement of knee or hip in osteoarthritis management of very old patients, is it possible: current evidence and how to proceed? Emmanuel Maheu

Auditorium B

Osteosarcopenia: Elucidating bone, muscle and fat interactions

Chairperson: ‣ Gustavo Duque

‣ Osteosarcopenia: Where bone, muscle and fat collide Gustavo Duque

‣ Diagnostic approach to osteosarcopenia Alexandra Papaioannou

‣ Osteosarcopenia: Potential Therapeutic Interventions Liang‑Kung Chen

08.00 - 09.00

SYMPOSIUM

Meeting Room 342A

Recommendations for the conduct of the economic evaluation in osteoporosis: outcomes of an experts consensus meeting organized under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF) USA branch

Chairpersons: ‣ Stuart Silverman, ‣ Mickaël Hiligsmann

‣ 08:00: Welcome and scope of the problem Stuart Silverman

‣ 08:05: Recommendations for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Mickaël Hiligsmann

‣ 08:25: Challenges, uncertainties and future research agenda for the conduct of economic evaluations in osteoporosis: a summary from an ESCEO-IOF USA Working Group Stuart Silverman

‣ 08:40: Discussion Panel

‣ 08:55: Conclusion Mickaël Hiligsmann

Panel: ‣ Susan Bukata, ‣ Philippe Halbout, ‣ Mickaël Hiligsmann, ‣ Famida Jiwa, ‣ Mike Lewiecki, ‣ Daniel Pinto, ‣ Jean‑Yves Reginster, ‣ Kenneth Saag, ‣ Stuart Silverman, ‣ Anna N. A. Tosteson

08.00 - 09.00

Meeting Room 101‑102‑103

Programme at a glance

Programme at a glance, Paris

Useful Information

Next congress